Jingcheng Dong
Overview
Explore the profile of Jingcheng Dong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
149
Citations
1769
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan F, Fouad D, Ataya F, Saeed U, Ji X, Dong J
Cell Mol Biol (Noisy-le-grand)
. 2025 Jan;
70(12):65-72.
PMID: 39799495
Mitochondrial ribosomal protein S23 (MRPS23), encoded by a nuclear gene, is a well-known driver of proliferation in cancer. It participates in mitochondrial protein translation, and its expression association has been...
2.
Khan F, Fouad D, Ataya F, Fang N, Dong J, Ji S
Biol Direct
. 2024 Nov;
19(1):104.
PMID: 39511680
Background: The growing body of evidence suggests that RNA-binding proteins (RBPs) have an important function in cancer biology. This research characterizes the expression status of fragile X-related protein 1 (FXR1)...
3.
Zhu X, Shen C, Dong J
BMC Cancer
. 2024 Oct;
24(1):1225.
PMID: 39363284
Background: In recent years, clinicians often encounter patients with multiple pulmonary nodules in their clinical practices. As most of these ground glass nodules (GGNs) are small in volume and show...
4.
Zhu X, Wang B, Yu H, Li C, Zhao Y, Zhong Y, et al.
J Gene Med
. 2024 Jul;
26(7):e3718.
PMID: 38979822
Background: Icariin (ICA) inhibits inflammatory response in various diseases, but the mechanism underlying ICA treating airway inflammation in asthma needs further understood. We aimed to predict and validate the potential...
5.
Kong Q, Zhu H, Dong J, Liu B
J Gene Med
. 2024 Jul;
26(7):e3710.
PMID: 38967229
Background: Patients with non-small cell lung cancer (NSCLC) are susceptible to coronavirus disease-2019 (COVID-19), but current treatments are limited. Icariside II (IS), a flavonoid compound derived from the plant epimedin,...
6.
Khan F, Nsengimana B, Awan U, Ji X, Ji S, Dong J
Cancer Gene Ther
. 2024 Jun;
31(10):1439-1453.
PMID: 38839892
Post-transcriptional RNA modification is an emerging epigenetic control mechanism in cells that is important in many different cellular and organismal processes. N6-methyladenosine (mA) is one of the most prevalent, prolific,...
7.
Deng L, Ouyang B, Tang W, Wang N, Yang F, Shi H, et al.
Phytomedicine
. 2024 May;
130:155687.
PMID: 38759312
Background: Idiopathic pulmonary fibrosis (IPF) is a debilitating interstitial lung disorder characterized by its limited therapeutic interventions. Macrophages, particularly the alternatively activated macrophages (M2 subtype), have been acknowledged for their...
8.
Shi H, Duan X, Dong J, Tao Y, Lei Y
J Ethnopharmacol
. 2024 Feb;
326:117963.
PMID: 38387680
Ethnopharmacological Relevance: Liver fibrosis is a serious complication of liver disease characterized by excessive collagen deposition, without effective therapeutic agents in the clinic. Fu-Gan-Wan (FGW) is an empirical formula used...
9.
Liu J, Sun Y, Chen W, Deng L, Chen M, Dong J
BMC Complement Med Ther
. 2023 Dec;
23(1):461.
PMID: 38102661
Background: Astragaloside III (AS III), a saponin-like metabolite derived from the traditional Chinese medicine Astragali Radix, has been shown to be effective in the treatment of cancer and heart failure,...
10.
Kong Q, Wang B, Zhong Y, Chen W, Sun J, Liu B, et al.
J Ethnopharmacol
. 2023 Dec;
321:117497.
PMID: 38048893
Ethnopharmacological Relevance: Chronic obstructive pulmonary disease (COPD) is a major global health concern characterized by pulmonary inflammation and airway remodeling. Traditional Chinese medicine, such as Modified Jiawei Bushen Yiqi Formula...